| abstract |
The present invention provides a low molecular weight inhibitor that inhibits caspase-3 activity, and more specifically, a novel low molecular weight inhibitor that does not have a peptide skeleton recognized as being highly useful as a pharmaceutical product. A caspase-3 activity inhibitor comprising a compound having a specific pharmacophore or a salt thereof, and an apoptosis inhibitor based on the caspase-3 activity inhibitory activity. [Selection figure] None |